Previous Close | 26.59 |
1-Year Change | -14.61% |
6-Months Change | 23.04% |
3-Months Change | 50.48% |
Moving Avg (50d) | 20.403 |
Moving Avg (200d) | 20.726 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.23B |
Beta (3-Years) | 0.7 |
Revenue Growth (ttm) | 1.78% |
Net Profit Margin (ttm) | 1.05% |
Return On Assets (ttm) | 0.46% |
EPS (ttm) | 0.09 |
PE Ratio (ttm) | 295.44 |
Dividend Yield | % |
Asset Description: | Pacira BioSciences, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-12-04 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
26.058 | 25.261 | 24.729 | 23.931 | 22.602 | 21.272 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.